Join to View Full Profile
44 Binney St"# D1542"Boston, MA 02115
Phone+1 617-632-6689
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Levi Garraway, MD is an oncologist in Boston, Massachusetts. He is an Associate Professor at Harvard Medical.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2005
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2001
Harvard Medical SchoolClass of 1999
Publications & Presentations
PubMed
- 1 citationsA compendium of Amplification-Related Gain Of Sensitivity genes in human cancer.Veronica Rendo, Michael Schubert, Nicholas Khuu, Maria F Suarez Peredo Rodriguez, Declan Whyte
Nature Communications. 2025-01-27 - 1 citationsA standing platform for cancer drug development using ctDNA-based evidence of recurrence.Arielle J Medford, Ariel B Carmeli, Alexandra Ritchie, Nikhil Wagle, Levi Garraway
Nature Reviews. Cancer. 2024-11-01 - 34 citationsAn activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.Abhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser, Marit Melssen, Itay Tirosh
Cancer Cell. 2022-05-09
Press Mentions
CHMP Recommends EU Label Update for Roche’s Phesgo to Allow Administration Outside of Clinical SettingsApril 29th, 2025- Roche Columvi Gets European Commission Nod as Bispecific Antibody for Diffuse Large B-cell Lymphoma After Initial TherapyApril 13th, 2025
- Roche to Share Latest Scientific Advancements from Its Neuromuscular Portfolio at Muscular Dystrophy Association (MDA) 2025 ConferenceMarch 16th, 2025
- Join now to see all
